What Is Ebola? Symptoms, Causes & Treatment

Author profile photo
What Is Ebola? Symptoms, Causes & Treatment

Ebola (Ebola virus disease, or EVD) is a rare but severe illness caused by a group of viruses called orthoebolaviruses, which trigger high fever, extreme fatigue, and — in advanced cases — dangerous bleeding and organ failure. It spreads through direct contact with the blood or body fluids of an infected person or animal, not through the air. Caught early, Ebola is survivable with the right supportive care, and for one strain (Zaire virus) two FDA-approved treatments and a vaccine now exist. Below, we break down the causes, the full symptom timeline, current treatment options, and what’s happening with the active 2026 outbreak in Central Africa — which has now spread beyond the Democratic Republic of the Congo (DRC) into Kenya and Nigeria and become the second-largest Ebola outbreak ever recorded.

Updated in early November 2026 with the latest case data, outbreak developments, and vaccine trial news from the DRC, Uganda, Kenya, and Nigeria.

What Is Ebola?

Ebola disease is caused by orthoebolaviruses (formerly called ebolaviruses), a family of viruses first identified in 1976 near the Ebola River in the Democratic Republic of the Congo (DRC). According to the CDC, these viruses are found primarily in sub-Saharan Africa and can cause mortality rates as high as 80–90% in the worst outbreaks, though the actual fatality rate varies significantly by virus species and access to care.

There are four orthoebolavirus species known to cause illness in people:

  • Zaire virus — causes Ebola virus disease (EVD), the most common and historically most fatal strain
  • Sudan virus — causes Sudan virus disease (SVD)
  • Bundibugyo virus — causes Bundibugyo virus disease (BVD), the strain behind the 2026 outbreak
  • Taï Forest virus — the rarest strain, with only one known human case

The Current Ebola Outbreak (2026 Update)

The Ebola outbreak caused by the Bundibugyo virus — the 17th recorded Ebola outbreak in the DRC since 1976 — has grown into the second-largest Ebola outbreak ever documented, behind only the 2014–2016 West Africa epidemic. It is also the largest outbreak ever recorded in the DRC’s history and the largest Bundibugyo virus outbreak on record. A CDC analysis found it had roughly seven times more cases in its first 100 days than the 2014 West Africa outbreak, making it the fastest-expanding Ebola outbreak ever documented. The World Health Organization declared it a Public Health Emergency of International Concern (PHEIC) on May 17, 2026 — a designation that remains in effect.

CountryConfirmed CasesDeathsStatus
DRC10,1934,960Active; community transmission ongoing
Kenya92Active; all cases linked to one imported case
Nigeria10Patient medically evacuated to Switzerland
Uganda202Declared Ebola-free by WHO, August 2026

Source: European Centre for Disease Prevention and Control, DRC data reported 28 October 2026 (as of 27 October). Case counts change by the day and are regularly revised as investigations continue, so check the source link for the latest totals. Ituri Province remains the epicenter, with roughly 7,200 cases and over 3,300 deaths reported across 28 of its 36 health zones; Nord-Kivu is the second-most affected province. In total, the outbreak has now reached 8 of the DRC’s 26 provinces (Ituri, Nord-Kivu, Sud-Kivu, Tshopo, Haut-Uélé, Bas-Uélé, Sud Ubangi, and Nord Ubangi) and 66 health zones.

Spread Beyond the DRC: Kenya, Nigeria, and Global Risk

Until October 2026, transmission linked to this outbreak had been confined to the DRC and Uganda. That changed when Kenya confirmed its first case on October 6 — a man who had traveled from the DRC through Uganda and died shortly after arriving in Nairobi — followed by eight more cases among his contacts, including a second death. On October 20, Nigeria confirmed its first case, in Abuja, in a patient who had traveled from Uganda via Ethiopia; the patient was medically evacuated to Switzerland on October 26 for specialized care, per ECDC reporting. Several healthcare and humanitarian workers have also been medically evacuated to Europe over the course of the outbreak — to Germany, France, the Netherlands, and the United Kingdom — without triggering any onward transmission there.

Despite the spread to four countries, ECDC currently assesses the risk to the EU/EEA population as very low, and the WHO continues to advise against blanket travel or trade restrictions. Still, the U.S. State Department has maintained a Level 4 “Do Not Travel” advisory for the DRC, and several countries have issued enhanced travel health notices and airport screening for travelers from affected areas. If you’re planning travel to or from Central or East Africa, check the CDC’s current travel health notices before you go, since advisory levels have been adjusted repeatedly as the outbreak has evolved.

A Vaccine Trial Has Finally Begun

Because no vaccine has ever been proven effective against the Bundibugyo strain, that gap has been one of the defining challenges of this outbreak. That started to change on October 23, 2026, when the first participants were vaccinated in Bunia, Ituri Province, as part of the Tumaini trial (“hope” in Swahili) — a pivotal Phase 2/3 study coordinated by the Coalition for Epidemic Preparedness Innovations (CEPI), the DRC Ministry of Health, WHO, and research partners including the Institut National de Recherche Biomédicale (INRB) and Médecins Sans Frontières. The trial uses a ring-vaccination design, offering candidate vaccines to the contacts of confirmed cases. It opened with ERVEBO (the vaccine already licensed against Zaire virus, whose effectiveness against Bundibugyo virus is unproven), with Bundibugyo-specific candidates from Moderna and the University of Oxford/Serum Institute of India expected to join shortly after. CEPI’s leadership has said a successful result would provide the first clear evidence of vaccine efficacy against Bundibugyo virus — a potential turning point for this outbreak and for future preparedness.

“Ebola caused by the Bundibugyo virus can be survived with good medical care… seeking care early makes a real difference.”

— Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, May 30, 2026

How the 2026 Outbreak Compares to Past Ebola Epidemics

Ebola has caused more than three dozen documented outbreaks since 1976, but only a handful have ever reached more than a few hundred cases. Here’s how the major outbreaks compare to the current one:

OutbreakVirus SpeciesCasesDeathsApprox. CFR
1976, Yambuku, Zaire (now DRC)Zaire virus318280~88%
1976, Nzara, SudanSudan virus284151~53%
1995, Kikwit, DRCZaire virus315250~79%
2000–2001, Gulu, UgandaSudan virus425224~53%
2007, Bundibugyo, UgandaBundibugyo virus14937~25%
2012, Isiro, DRCBundibugyo virus5729~51%
2014–2016, West AfricaZaire virus28,61611,310~40%
2018–2020, North Kivu/Ituri, DRCZaire virus3,4702,280~66%
2022, UgandaSudan virus16455~34%
2026 (ongoing), DRC, Kenya, Nigeria, UgandaBundibugyo virus10,200+4,960+~49%

Two things make the current outbreak stand out. First, its sheer scale: it has already infected roughly three times more people than the 2018–2020 DRC outbreak that was, until now, the country’s worst. Second, its speed — case numbers climbed faster in the first 100 days than in any previous Ebola outbreak on record. Only the 2014–2016 West Africa epidemic, which unfolded over nearly three years and eventually reached ten countries, remains larger in absolute terms.

What Causes Ebola? (How Do You Get It?)

How Ebola Spreads

Ebola is not airborne and does not spread the way flu or COVID-19 does — you can’t catch it from being near an infected person. Per the CDC, transmission requires direct contact with:

  • Blood, vomit, urine, feces, saliva, sweat, breast milk, or semen from an infected person
  • Contaminated surfaces, clothing, bedding, needles, or medical equipment
  • The body of someone who has died from Ebola (a major risk during traditional burial practices)
  • Infected animals, especially fruit bats and non-human primates, or their raw meat

A person only becomes contagious once they start showing symptoms — not during the incubation period.

Types of Ebola Virus at a Glance

Virus SpeciesDiseaseApprox. Fatality RateApproved Treatment?
Zaire virusEbola virus disease (EVD)~50% historically (up to 90%)Yes — Inmazeb, Ebanga, ERVEBO vaccine
Sudan virusSudan virus disease~50%No
Bundibugyo virusBundibugyo virus disease25%–50%No (Phase 2/3 vaccine trial underway as of Oct. 2026)
Taï Forest virusTaï Forest virus diseaseExtremely rare; limited dataNo

Who’s Most at Risk?

Anyone in close contact with a sick person’s body fluids can contract Ebola, but some groups face substantially higher exposure risk:

  • Healthcare workers treating Ebola patients, especially without adequate personal protective equipment
  • Family members and caregivers of someone who is sick
  • People who handle the bodies of the deceased, including during traditional burial and funeral rites
  • Hunters, traders, and consumers of bushmeat from fruit bats or primates
  • Laboratory workers handling samples from suspected cases or infected animals

This is also why the current outbreak has been so difficult to contain: active armed conflict and large-scale displacement across eastern DRC have repeatedly disrupted contact tracing, safe burial practices, and access to care in the hardest-hit provinces.

Ebola Symptoms: The Full Timeline

Symptoms typically begin 8 to 10 days after exposure, though the incubation period can range from 2 to 21 days, per the CDC. Ebola symptoms usually progress in two phases:

Early “Dry” Symptoms

  • Sudden fever
  • Severe fatigue
  • Muscle and joint pain
  • Headache
  • Sore throat

Later “Wet” Symptoms

As the illness progresses, patients often develop:

  • Vomiting and diarrhea
  • Rash
  • Impaired kidney and liver function
  • Unexplained internal or external bleeding
  • In severe cases, multi-organ failure

Because early symptoms overlap with malaria, typhoid, and the flu, Ebola is easy to miss without a known exposure history — which is exactly why lab testing matters in an active outbreak area.

How Is Ebola Diagnosed?

Healthcare providers confirm Ebola using a PCR (polymerase chain reaction) blood test, which detects viral genetic material. Antibody testing can also show whether someone was previously infected. Anyone being tested is isolated from other patients until results come back, since even a suspected case requires strict infection control.

Ebola Treatment Options

FDA-Approved Treatments (Zaire Virus Only)

Two monoclonal antibody therapies are FDA-approved, but only for Ebola disease caused by the Zaire species:

  • Inmazeb™ — a cocktail of three monoclonal antibodies
  • Ebanga™ — a single monoclonal antibody

Neither drug is approved for Sudan, Bundibugyo, or Taï Forest virus, which is a key reason the 2026 outbreak has been so difficult to treat. Antiviral candidates including remdesivir and the monoclonal antibodies MBP-134 and maftivimab remain in various stages of development for non-Zaire strains, and — as of October 2026 — the first pivotal efficacy trial of a vaccine against Bundibugyo virus (the Tumaini trial, described above) is now underway in the DRC.

Supportive Care

Regardless of strain, early supportive care significantly improves survival odds. This includes:

  • IV fluids and electrolyte (body salt) replacement
  • Medications to stabilize blood pressure
  • Treatment for nausea, vomiting, and diarrhea
  • Pain and fever management
  • Treating any secondary infections

Life After Ebola: Long-Term Effects & Post-Ebola Syndrome

Surviving the acute illness isn’t always the end of the story. Studies of Ebola survivors — mostly following the 2014–2016 West Africa epidemic — have documented a cluster of lingering symptoms doctors now refer to as post-Ebola syndrome, which can persist for months or even years after someone tests negative for the virus. Reported symptoms include:

  • Joint and muscle pain, reported by roughly half to more than three-quarters of survivors across various studies
  • Persistent fatigue and headaches
  • Hair loss
  • Memory problems, insomnia, and other cognitive or psychological symptoms, including anxiety and depression
  • Uveitis (eye inflammation), reported in roughly 1 in 5 to 1 in 3 survivors in some cohorts, which can cause permanent vision loss or blindness if left untreated
  • Hearing loss, in some survivors

Researchers still don’t fully understand why Ebola triggers these aftereffects, though ongoing immune activation is thought to play a role. Because eye problems can emerge or worsen well after other symptoms resolve, survivor-care guidance increasingly emphasizes long-term medical follow-up, including regular eye exams. Anyone who has recovered from Ebola and develops new or worsening joint pain, vision changes, or persistent fatigue should raise it with a healthcare provider, ideally one connected to a survivor-care program.

Can Ebola Be Prevented?

The FDA-approved vaccine ERVEBO® protects against the Zaire strain only and is recommended for adults 18+ at risk of exposure. It is not effective enough against the Bundibugyo strain to be recommended in the current outbreak — the WHO advised against using it there in May 2026 due to insufficient evidence of cross-protection. That’s exactly what the Tumaini trial, which began vaccinating participants in October 2026, is now trying to establish; until results are in, ERVEBO is being tested only in a research setting for this outbreak, not offered as routine prevention.

If you’re in or traveling to an area with an active outbreak, the CDC recommends:

  • Avoiding contact with blood and body fluids of sick individuals
  • Avoiding contact with bats, primates, and bushmeat
  • Not attending funerals or burial rituals that involve touching the body
  • Wearing personal protective equipment around anyone who may be infected
  • Monitoring your health for 21 days after possible exposure and seeking care immediately if symptoms appear

Ebola Survival Rate: What’s the Outlook?

Survival depends heavily on the virus species, how quickly treatment begins, and access to quality healthcare. Historical Ebola outbreaks have had fatality rates ranging from roughly 25% to 90%. In the current Bundibugyo outbreak, the case fatality rate sits at roughly 49% — in line with historical Bundibugyo outbreaks — and thousands of patients have already recovered across the DRC, Kenya, and Uganda. That’s evidence that early treatment-seeking behavior and supportive care directly improve outcomes, even without a targeted antiviral or proven vaccine for this strain.

Frequently Asked Questions About Ebola

What is Ebola virus disease?

Ebola virus disease (EVD) is a severe, often fatal illness caused by orthoebolaviruses. It causes fever, fatigue, and body aches early on, potentially progressing to vomiting, diarrhea, and dangerous bleeding in later stages.

How do you catch Ebola?

You catch Ebola through direct contact with the blood or body fluids of an infected person or animal, or by touching contaminated surfaces, clothing, or medical equipment. It does not spread through casual contact or air.

What are the first signs of Ebola?

The earliest signs are sudden fever, severe fatigue, muscle and joint pain, headache, and sore throat, typically appearing 8 to 10 days after exposure.

Is there a cure for Ebola?

There is no universal cure. Two FDA-approved antibody treatments, Inmazeb and Ebanga, work specifically against the Zaire strain. Other strains, including the Bundibugyo virus behind the 2026 outbreak, still have no approved treatment and rely on supportive care — though a pivotal vaccine trial (Tumaini) launched in the DRC in October 2026 to test candidate vaccines against Bundibugyo virus specifically.

Is Ebola airborne?

No. Ebola does not spread through the air like flu or COVID-19. You cannot get it from being near an infected person without direct contact with their body fluids.

What is the current Ebola outbreak in 2026?

An outbreak of Bundibugyo virus disease has been affecting the DRC since May 2026, and has since spread to Uganda (where it was declared over in August 2026), Kenya, and Nigeria. As of late October 2026, the DRC has reported over 10,100 confirmed cases and nearly 5,000 deaths, making this the second-largest Ebola outbreak ever recorded and the largest in the DRC’s history.

How deadly is Ebola?

Fatality rates vary by strain, ranging from roughly 25% to as high as 90% in the worst historical outbreaks; the current 2026 outbreak has a case fatality rate of around 49%. Early treatment and access to supportive care significantly improve survival odds.

Has Ebola spread beyond the Democratic Republic of Congo?

Yes. As of late October 2026, locally confirmed or imported cases linked to this outbreak have been reported in the DRC, Uganda (now declared over), Kenya, and Nigeria, in addition to several healthcare workers medically evacuated to Europe for treatment. Health agencies currently assess the risk to the general public outside these countries as very low, though they continue to monitor the situation closely.

What is post-Ebola syndrome?

It’s a cluster of lingering symptoms — including joint pain, fatigue, memory problems, and eye inflammation that can threaten vision — that some survivors experience for months or years after recovering from the acute infection. Survivors are encouraged to seek ongoing medical follow-up, particularly for eye health.

What’s the difference between Ebola and Marburg virus?

They’re closely related viruses in the same family (Filoviridae) that cause similarly severe hemorrhagic fevers, with comparable symptoms, transmission routes, and fatality rates (roughly 25%–90%). Marburg virus is carried by Egyptian fruit bats and was first identified in 1967. Like Bundibugyo virus, it currently has no FDA-approved vaccine or treatment, although candidates are in development.

Could this outbreak reach the United States or Europe?

Several healthcare workers linked to the outbreak have been medically evacuated to Europe for treatment without triggering further spread there, and European health authorities currently rate the risk to the EU/EEA population as very low. No cases connected to this outbreak have been reported in the United States. Still, public health agencies recommend that travelers to or from affected countries stay informed via the CDC’s travel health notices, since screening measures and advisory levels can change quickly.

Also Read: Pancreatic Cancer Vaccine: How It Works, Benefits, Side Effects

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you suspect Ebola exposure, contact a healthcare provider or your local health authority immediately.